Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.
about
Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitusAssociations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik EskimosGene expression and biological pathways in tissue of men with prostate cancer in a randomized clinical trial of lycopene and fish oil supplementationNutritional profiles in a public health perspective: a critical review.Algal docosahexaenoic acid affects plasma lipoprotein particle size distribution in overweight and obese adults.Effects of Omega-3 Fatty Acid Supplementation on Glucose Control and Lipid Levels in Type 2 Diabetes: A Meta-Analysis.Evaluation of lipid profiles and the use of omega-3 essential Fatty Acid in professional football players.Thematic review series: patient-oriented research. Nutritional determinants of insulin resistance.Omega-3 Polyunsaturated Fatty Acids May Attenuate Streptozotocin-Induced Pancreatic β-Cell Death via Autophagy Activation in Fat1 Transgenic Mice.Inflammation, obesity, and fatty acid metabolism: influence of n-3 polyunsaturated fatty acids on factors contributing to metabolic syndrome.Omega-3 polyunsaturated fatty acid and insulin sensitivity: a meta-analysis of randomized controlled trials.Dietary stimulators of GLUT4 expression and translocation in skeletal muscle: a mini-review.Peripartal feeding strategy with different n-6:n-3 ratios in sows: effect on gene expression in backfat white adipose tissue postpartum.Adipose tissue compensates for defect of phosphatidylinositol 3'-kinase induced in liver and muscle by dietary fish oil in fed rats.Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta-analysis of randomised placebo-control human clinical trials.Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial.The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.Fish oil supplemented for 9 months does not improve glycaemic control or insulin sensitivity in subjects with impaired glucose regulation: a parallel randomised controlled trial.The association between n-3 fatty acids in erythrocyte membranes and insulin resistance: the Inuit Health in Transition Study.Effects of n-3 fatty acids and exercise on oxidative stress parameters in type 2 diabetic: a randomized clinical trial.
P2860
Q24242688-DB3CDA9A-9AA4-4D87-9779-91DC7E5E1594Q33666208-C6896197-10D9-4B05-97F6-86A5DC22916AQ34017813-697887B5-F54F-49BF-B42F-018D7790B259Q34118460-FF4206F7-D31F-42A9-B55C-996D6F930D08Q34493093-4B6D4D7B-1D89-4541-AAF2-0A643DA0EACCQ35797277-E8301D2D-446D-4143-B89C-CB473FED85AAQ36242160-C3202F59-C8B4-4D62-8F22-32566D82122DQ36487060-D86F11F5-5305-472E-8C9B-55118FD637E5Q36489182-7E892E55-6BD6-4C00-B65F-8E8969BC8EFCQ37024566-91DD007C-5130-4D2A-A70E-A9EE2A8D62D3Q37344184-D4EC8CDA-04E4-4672-94FF-18FDB00723CFQ38248623-B3C5F730-F797-45DE-8E0D-6AB9EC0034EBQ46579916-02E3933E-0EA5-4B5A-9B15-FC18E929CFFCQ46844353-CC001F1D-01F4-4BE7-A23A-6052D6F81D9BQ48181231-DD192C07-5FD3-4F95-BD0C-999A4962333AQ51088875-DACEF885-86E4-4FB2-AF8E-B6BA73F2C15FQ51281402-195CB185-4528-4EE6-8252-E737C3C697A6Q51294540-5CE88F70-42B2-4BE0-B940-51B3583D3112Q51411989-6A383B6B-E221-4CB6-9900-EE2FDB77B8F9Q55194336-E125548D-2444-4D4D-9DF0-04DC62A5C83D
P2860
Moderate intake of n-3 fatty acids for 2 months has no detrimental effect on glucose metabolism and could ameliorate the lipid profile in type 2 diabetic men. Results of a controlled study.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Moderate intake of n-3 fatty a ...... Results of a controlled study.
@en
Moderate intake of n-3 fatty a ...... Results of a controlled study.
@nl
type
label
Moderate intake of n-3 fatty a ...... Results of a controlled study.
@en
Moderate intake of n-3 fatty a ...... Results of a controlled study.
@nl
prefLabel
Moderate intake of n-3 fatty a ...... Results of a controlled study.
@en
Moderate intake of n-3 fatty a ...... Results of a controlled study.
@nl
P2093
P356
P1433
P1476
Moderate intake of n-3 fatty a ...... Results of a controlled study
@en
P2093
A Boussairi
A Chevalier
A S Chapuis
J M Oppert
M Guerre-Millo
S W Rizkalla
P304
P356
10.2337/DIACARE.21.5.717
P407
P50
P577
1998-05-01T00:00:00Z